Skip to main navigation Skip to search Skip to main content

A gallium telluride quantum dots bioelectrode system for human epidermal growth factor receptor-2 (Her2/neu) oncogene signalling

  • Xolile Fuku
  • , Baljit Singh
  • , Rachel F. Ajayi
  • , Abongile N. Jijana
  • , Priscilla Baker
  • , Eithne Dempsey
  • , Emmanuel Iwuoha

Research output: Contribution to journalArticlepeer-review

Abstract

Human epidermal growth factor receptor 2 (Her2/neu) is a biomarker that is overexpressed in human breast cancers. A quantum dots (QDs) -based genosensor for Her2/neu oncogene was developed with gallium telluride QDs and amine-terminated probe ssDNA (NH2-5′-AATTCCAGTGGCCATCAA-3′), that is complementary to the DNA sequence of a section of the ERF gene of HER-2/neu (i.e. 5′-GAACATGAAGGACCGGTGGGC-3′). The QDs were highly crystalline, 6 nm (from XRD) in size and had band gap values of 3.3 eV and 3.5 eV calculated from fluorescence emission and UV-visible absorption data, respectively. The sensor sensitivity and limit of detection values were 10.0 μA ng-1 mL-1 and 0.2 pg mL-1 Her2/neu oncogene, respectively.

Original languageEnglish
Pages (from-to)6114-6124
Number of pages11
JournalAnalytical Methods
Volume7
Issue number15
DOIs
Publication statusPublished - 7 Aug 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'A gallium telluride quantum dots bioelectrode system for human epidermal growth factor receptor-2 (Her2/neu) oncogene signalling'. Together they form a unique fingerprint.

Cite this